Keeping faith with trial volunteers
作者： Martine Piccart , Aron Goldhirsch , William Wood , Kathleen Pritchard , José Baselga
DOI: 10.1038/446137A
关键词: Breast cancer 、 Bioinformatics 、 Molecular interactions 、 Early breast cancer 、 Science policy 、 Faith 、 Biology 、 Family medicine 、 Prospective trial 、 Clinical trial 、 Independence
摘要: How best to serve patients' interests in large clinical trials? Martine Piccart, Aron Goldhirsch and their colleagues argue that maintaining academic independence is essential early breast cancer trials. Recent cases of the misreporting trial results, a trend for some drug companies seek more control over data trials produce, could deter prospective patients. In Commentary this week group clinicians working on therapy argues maintenance key proper conduct trials, continued support from public.
ulb.ac.be
harvard.edu
core.ac.uk
nature.com
sci-hub.se 参考文章(10)
A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer The New England Journal of Medicine. ,vol. 353, pp. 2747- 2757 ,(2005) , 10.1056/NEJMOA052258
Early Breast Cancer Trialists' Collaborative Group, None, Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials The Lancet. ,vol. 365, pp. 1687- 1717 ,(2005) , 10.1016/S0140-6736(05)66544-0
Jeffrey M. Drazen, Institutions, Contracts, and Academic Freedom New England Journal of Medicine. ,vol. 347, pp. 1362- 1363 ,(2002) , 10.1056/NEJME020122
Paul E. Goss, James N. Ingle, Silvana Martino, Nicholas J. Robert, Hyman B. Muss, Martine J. Piccart, Monica Castiglione, Dongsheng Tu, Lois E. Shepherd, Kathleen I. Pritchard, Robert B. Livingston, Nancy E. Davidson, Larry Norton, Edith A. Perez, Jeffrey S. Abrams, Patrick Therasse, Michael J. Palmer, Joseph L. Pater, A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer New England Journal of Medicine. ,vol. 349, pp. 1793- 1802 ,(2003) , 10.1056/NEJMOA032312
Meredith M. Regan, Richard D. Gelber, Predicting response to systemic treatments: Learning from the past to plan for the future The Breast. ,vol. 14, pp. 582- 593 ,(2005) , 10.1016/J.BREAST.2005.08.021
Michelle M. Mello, Brian R. Clarridge, David M. Studdert, Academic Medical Centers' Standards for Clinical-Trial Agreements with Industry The New England Journal of Medicine. ,vol. 352, pp. 2202- 2210 ,(2005) , 10.1056/NEJMSA044115
Sharon H. Giordano, Zhigang Duan, Yong-Fang Kuo, Gabriel N. Hortobagyi, James S. Goodwin, Use and Outcomes of Adjuvant Chemotherapy in Older Women With Breast Cancer Journal of Clinical Oncology. ,vol. 24, pp. 2750- 2756 ,(2006) , 10.1200/JCO.2005.02.3028
Martine J. Piccart-Gebhart, Marion Procter, Brian Leyland-Jones, Aron Goldhirsch, Michael Untch, Ian Smith, Luca Gianni, Jose Baselga, Richard Bell, Christian Jackisch, David Cameron, Mitch Dowsett, Carlos H. Barrios, Günther Steger, Chiun-Shen Huang, Michael Andersson, Moshe Inbar, Mikhail Lichinitser, István Láng, Ulrike Nitz, Hiroji Iwata, Christoph Thomssen, Caroline Lohrisch, Thomas M. Suter, Josef Rüschoff, Tamás Sütő, Victoria Greatorex, Carol Ward, Carolyn Straehle, Eleanor McFadden, M. Stella Dolci, Richard D. Gelber, Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer The New England Journal of Medicine. ,vol. 353, pp. 1659- 1672 ,(2005) , 10.1056/NEJMOA052306
R. Charles Coombes, Emma Hall, Lorna J. Gibson, Robert Paridaens, Jacek Jassem, Thierry Delozier, Stephen E. Jones, Isabel Alvarez, Gianfilippo Bertelli, Olaf Ortmann, Alan S. Coates, Emilio Bajetta, David Dodwell, Robert E. Coleman, Lesley J. Fallowfield, Elizabeth Mickiewicz, Jorn Andersen, Per E. Lønning, Giorgio Cocconi, Alan Stewart, Nick Stuart, Claire F. Snowdon, Marina Carpentieri, Giorgio Massimini, Judith M. Bliss, A Randomized Trial Of Exemestane After Two To Three Years Of Tamoxifen Therapy In Postmenopausal Women With Primary Breast Cancer. The New England Journal of Medicine. ,vol. 350, pp. 1081- 1092 ,(2004) , 10.1056/NEJMOA040331
James Khatcheressian, Thomas J Smith, Review: chemotherapy and hormonal therapy reduce recurrence and mortality at 15 years in early breast cancer Early Breast Cancer Trialists' Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;365:1687-717. ,(2005)